In a recent government meeting, the University of Hawaii received approval to import and conduct laboratory research on the monkeypox virus, classified as a BSL2 pathogen. The request, which aims to enhance understanding of the virus and its implications for public health, was presented by Will Leongrero, a microorganisms specialist from the plant quarantine branch.

The board discussed the establishment of permit conditions for the importation and possession of the monkeypox virus, emphasizing the need for stringent safety measures. The subcommittee reviewing the request unanimously supported the importation, citing minimal environmental impact and the high-security measures in place at the university's Japsun building, which is equipped to handle BSL3 pathogens.

Dr. Saguna Verma, a professor at the university, explained the significance of researching monkeypox, particularly in light of its recent global spread. She highlighted that while the virus has historically been confined to Africa, it has now reached over 120 countries, necessitating further study to inform public health policies and antiviral development.

The board also addressed safety protocols, with Dr. Verma assuring that all personnel working with the virus would be vaccinated and trained in rigorous containment methods. These include the use of biosafety cabinets, double gloves, and a buddy system to ensure safety during laboratory work.

The meeting concluded with a consensus on the importance of advancing research on monkeypox to better understand its transmission and potential impacts on public health, marking a significant step for the University of Hawaii in virology research.